Stifel Nicolaus Lowers DocGo (NASDAQ:DCGO) Price Target to $5.50

DocGo (NASDAQ:DCGO) had its price target dropped by equities researchers at Stifel Nicolaus from $6.50 to $5.50 in a research note issued on Friday,Benzinga reports. The firm presently has a “buy” rating on the stock. Stifel Nicolaus’ price target would suggest a potential upside of 91.97% from the company’s previous close.

Several other research firms have also recently commented on DCGO. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and decreased their price target for the company from $5.00 to $2.85 in a research note on Friday. Needham & Company LLC reduced their price objective on DocGo from $7.00 to $4.00 and set a “buy” rating on the stock in a report on Friday. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $4.89.

DocGo Stock Performance

DCGO traded down $1.06 during midday trading on Friday, hitting $2.87. The company had a trading volume of 3,451,645 shares, compared to its average volume of 668,236. DocGo has a twelve month low of $2.75 and a twelve month high of $5.68. The company has a market capitalization of $292.38 million, a PE ratio of 10.18, a P/E/G ratio of 14.16 and a beta of 1.00. The firm’s 50-day simple moving average is $4.61 and its 200-day simple moving average is $4.02.

Insider Buying and Selling

In related news, General Counsel Ely D. Tendler sold 23,088 shares of DocGo stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the completion of the sale, the general counsel now directly owns 175,645 shares of the company’s stock, valued at $779,863.80. The trade was a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.70% of the stock is currently owned by insiders.

Hedge Funds Weigh In On DocGo

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DCGO. Summit Investment Advisors Inc. raised its position in shares of DocGo by 38.7% in the 4th quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock valued at $45,000 after acquiring an additional 2,968 shares during the period. Centiva Capital LP bought a new stake in DocGo in the third quarter valued at approximately $43,000. Prudential Financial Inc. bought a new stake in DocGo in the fourth quarter valued at approximately $55,000. Royce & Associates LP acquired a new stake in DocGo in the fourth quarter worth $64,000. Finally, Intech Investment Management LLC bought a new position in shares of DocGo during the third quarter worth $62,000. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.